As we recently reported variability of CTLA-4 expression and its functional relevance in the CLL compartment [19–21], we decided to investigate whether CLL patients differ in the pattern of CLL cell responses to CTLA-4 blockade. Here, CTLA4 is linked to B-cell chronic lymphocytic leukemia.